This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zendman, A. J. W. Articles by van Muijen, G. N. P. Search for Related Content PubMed PubMed Citation Articles by Zendman, A. J. W. Articles by van Muijen, G. N. P.

CTp11, a Novel Member of the Family of Human Cancer/Testis Antigens¹

Department of Pathology, University Hospital, 6500 HB Nijmegen, the Netherlands [A. J. W. Z., I. M. H. A. C., D. J. R., G. N. P. v. M.], and Roche Diagnostics GmbH, Pharma Research, D-82377 Penzberg, Germany [U. H. W.]

To identify new genes that may contribute to the metastatic pathway of neoplastic cells, we compared mRNA expression of the parental human melanoma cell line 1F6 and its metastatic variant 1F6m using mRNA differential display. We isolated a cDNA clone that was exclusively expressed in 1F6m. Northern blot analysis on a broader panel of human melanoma cell lines with different metastatic capacity following s.c. inoculation into nude mice demonstrated that the gene was expressed only in the most aggressive, highly metastatic cell lines, giving a band of 0.5 kb. The isolated full length cDNA clone showed an open reading frame of 97 amino acids. To study the subcellular localization of the gene product, COS-1 cells were transfected with cDNA of the gene fused to eGFP. We found the fusion protein to be exclusively present in the nucleus.

A computer search showed strong homology with human genomic clones all localized on chromosome X (Xq26.3-Xq27.1) and with several expressed sequence tags, all from testis. Localization of the gene on chromosome X was confirmed by genomic PCR on a panel of human chromosome-specific rodent/human hybrid cell lines.

Northern blotting and reverse transcription-PCR on 17 different normal human tissue samples showed that the gene was only expressed in normal testis. Reverse transcription-PCR on a great number of different human tumor cell lines showed expression in 25–30% of the melanoma and bladder carcinoma cell lines. Only 2 of 29 other tumor cell lines were positive. Nested PCR analysis of a series of fresh human melanocytic tumors demonstrated expression in 7 of 10 melanomas tested. No expression was seen in benign melanocytic tumors. In addition to melanoma, some malignant tumors from other histological types were also found to be positive.

Based on these data, we conclude that the described gene, CTp11 (cancer/testis-associated protein of 11 kDa), is a novel member of the family of cancer/testis antigens.

This article has been cited by other articles:

				G. Almanzar, P. B. Olkhanud, M. Bodogai, C. Dell'Agnola, D. Baatar, S. M. Hewitt, C. Ghimenton, M. K. Tummala, A. T. Weeraratna, K. S. Hoek, et al. Sperm-Derived SPANX-B Is a Clinically Relevant Tumor Antigen That Is Expressed in Human Tumors and Readily Recognized by Human CD4+ and CD8+ T Cells Clin. Cancer Res., March 15, 2009; 15(6): 1954 - 1963. [Abstract] [Full Text] [PDF]

				V.A. Westbrook, P.D. Schoppee, G.R. Vanage, K.L. Klotz, A.B. Diekman, C.J. Flickinger, M.A. Coppola, and J.C. Herr Hominoid-specific SPANXA/D genes demonstrate differential expression in individuals and protein localization to a distinct nuclear envelope domain during spermatid morphogenesis Mol. Hum. Reprod., November 1, 2006; 12(11): 703 - 716. [Abstract] [Full Text] [PDF]

				S Abdul-Rasool, S H Kidson, E Panieri, D Dent, K Pillay, and G S Hanekom An evaluation of molecular markers for improved detection of breast cancer metastases in sentinel nodes. J. Clin. Pathol., March 1, 2006; 59(3): 289 - 297. [Abstract] [Full Text] [PDF]

				T. Okada, M. Akada, T. Fujita, T. Iwata, Y. Goto, K. Kido, T. Okada, Y. Matsuzaki, K. Kobayashi, S. Matsuno, et al. A Novel Cancer Testis Antigen That Is Frequently Expressed in Pancreatic, Lung, and Endometrial Cancers Clin. Cancer Res., January 1, 2006; 12(1): 191 - 197. [Abstract] [Full Text] [PDF]

				N. Kouprina, A. Pavlicek, V. N. Noskov, G. Solomon, J. Otstot, W. Isaacs, J. D. Carpten, J. M. Trent, J. Schleutker, J. C. Barrett, et al. Dynamic structure of the SPANX gene cluster mapped to the prostate cancer susceptibility locus HPCX at Xq27 Genome Res., November 1, 2005; 15(11): 1477 - 1486. [Abstract] [Full Text] [PDF]

				N. Naka, S. Joyama, Y. Tsukamoto, K. Yoshioka, N. Hashimoto, T. Ujiiye, T. Hayashi, M. Kawase, M. Mano, S. Ishiguro, et al. Quantification of SSX mRNA Expression in Human Bone and Soft Tissue Tumors Using Nucleic Acid Sequence-Based Amplification J. Mol. Diagn., May 1, 2005; 7(2): 187 - 197. [Abstract] [Full Text] [PDF]

				N. Kouprina, M. Mullokandov, I. B. Rogozin, N. K. Collins, G. Solomon, J. Otstot, J. I. Risinger, E. V. Koonin, J. C. Barrett, and V. Larionov The SPANX gene family of cancer/testis-specific antigens: Rapid evolution and amplification in African great apes and hominids PNAS, March 2, 2004; 101(9): 3077 - 3082. [Abstract] [Full Text] [PDF]

				Z. Wang, Y. Zhang, H. Liu, E. Salati, M. Chiriva-Internati, and S. H. Lim Gene expression and immunologic consequence of SPAN-Xb in myeloma and other hematologic malignancies Blood, February 1, 2003; 101(3): 955 - 960. [Abstract] [Full Text] [PDF]

				T. Ono, T. Kurashige, N. Harada, Y. Noguchi, T. Saika, N. Niikawa, M. Aoe, S. Nakamura, T. Higashi, A. Hiraki, et al. Identification of proacrosin binding protein sp32 precursor as a human cancer/testis antigen PNAS, March 13, 2001; 98(6): 3282 - 3287. [Abstract] [Full Text] [PDF]

				V. Anne Westbrook, A. B. Diekman, S. Naaby-Hansen, S. A. Coonrod, K. L. Klotz, T. S. Thomas, E. J. Norton, C. J. Flickinger, and J. C. Herr Differential Nuclear Localization of the Cancer/Testis-Associated Protein, SPAN-X/CTp11, in Transfected Cells and in 50% of Human Spermatozoa Biol Reprod, January 1, 2001; 64(1): 345 - 358. [Abstract] [Full Text]